Developer docs
API playgroundTry for free, no card

Search company profiles

Cascade Cryobank

Full company profile

uuid00q7k8h

Namestring
Cascade Cryobank
Legal namestring
Cascade Cryobank LLC
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Cascade Cryobank is a Washington-state-based for-profit sperm bank founded in 2022 (per company history) and headquartered in Lynnwood, WA, operating as a wholly-owned subsidiary of Fertio, the international fertility care group that owns European Sperm Bank, following Fertio's March 2026 acquisition. The company recruits and screens sperm donors against an industry-rigorous bar — only about 4% of applicants are accepted — and processes donations through FDA-registered, CLIA-certified cryopreservation workflows meeting 21 CFR Part 1271, with state-level tissue bank licensure in Washington, New York, California, Colorado, Oregon, and Maryland, plus Health Canada Primary Establishment registration for cross-border distribution. Its core products are five cryopreserved vial types (IUI, ICI, IUI A.R.T., ICI A.R.T., and IVF/ICSI) sold direct-to-consumer via cascadecryobank.com, each with guaranteed post-thaw motile cell counts (e.g., $1,400-$2,300 per vial), supported by temperature-controlled FedEx shipping, optional long-term storage, and a CapexMD financing partnership.

The company's principal point of differentiation is the proprietary Early Disclosure Program, a first-of-its-kind identity-release framework that permits parents to access donor identifying information (name, date of birth, last known state) immediately after live birth reporting rather than at the donor-conceived child's 18th birthday, with counselor-facilitated meetings between donors and parents. Genetic depth is a second differentiator: each donor is screened against 714 recessive genetic conditions, including the seven recommended carrier conditions (SMA, sickle cell, alpha/beta thalassemia, Tay-Sachs, cystic fibrosis, fragile X), along with karyotype analysis and a four-generation family medical history.

Cascade Cryobank serves four primary customer segments — single parents by choice, LGBTQ+ individuals and couples, heterosexual couples facing male-factor infertility, and fertility clinics/reproductive healthcare providers — distributed through a hybrid DTC e-commerce plus B2B clinic coordination model. Geographic reach is anchored in the Pacific Northwest (Lynnwood HQ, with named service areas in Seattle, Portland, and Boise) but vials are shipped nationwide and now into Canada. Leadership combines founder/Medical Director Dr. John Carpenter (board-certified pathologist, Seattle-area practice since 2010) and COO Corey Burke (25+ years in reproductive health, prior EVP at Cryos International, contributed to 3,000+ births, 25+ FDA inspections led).

Short descriptiontext

Cascade Cryobank is a Washington-state-based FDA-registered sperm bank founded in 2022 and now a subsidiary of Fertio (European Sperm Bank's parent). It sells five cryopreserved donor sperm vial types direct-to-consumer and to fertility clinics across the U.S. and Canada, differentiated by its Early Disclosure Program and 714-condition genetic screening.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLynnwood, United States
HQ citystring
Lynnwood
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
sperm donor bank, cryopreserved donor sperm, assisted reproductive services, donor sperm vials, fertility specimen storage
Industry2 codes
PRIMARYHLAGAGAK
Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAAAJAN
Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
NAICS code1 code
  • Blood and Organ Banks621991
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Donor Sperm Vial Sales
TypeOne Time License
Description

Primary revenue from selling cryopreserved donor sperm vials. Different vial types available: IUI (washed), ICI (unprocessed), IUI A.R.T., ICI A.R.T., and IVF/ICSI vials. Pricing varies by disclosure type (Open ID vs Early Disclosure) and cell count specifications.

cascadecryobank.com
2Specimen Storage
TypeSubscription Recurring
Description

Long-term cold storage of purchased sperm vials. Free storage promotion offered with purchase of 2+ vials (number of vials + 2 additional months free). Storage fees apply after free period.

cascadecryobank.com
3Shipping and Delivery
TypeOne Time License
Description

Revenue from shipping specimens via FedEx in dry shippers. Standard continental US shipping $300 (2-day, Mon-Wed only), overnight priority $395 (Mon-Fri, delivery by noon). International and Alaska/Hawaii shipping available at higher rates.

cascadecryobank.com
4Sperm Donation Compensation
TypeProfessional Services
Description

Donors receive compensation: $40 per initial test donation, $125 per accepted donation ($50 at time of donation, $50 after freeze/thaw test, $25 after 6-month quarantine clearance). Monthly earnings can reach up to $1,400 with bonuses. Donors earning $600+/year receive 1099 tax forms.

cascadecryobank.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Marketing or Sales, Supply Chain, Technology or R&D, Infrastructure
Pricing details7 tiers
1IUI 10 Open ID - Washed specimens for insemination procedures with 10+ million motile cells
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$1,700 per vial - Can be used for all insemination procedures including IUI, ICI, at-home insemination, IVF, and ICSI. Guaranteed 10+ million motile sperm cells per 0.5 mL.

cascadecryobank.com
2IUI 10 Early Disclosure - Premium identity disclosure option with same specifications
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$2,300 per vial - Same specifications as Open ID but with Early Disclosure Program access allowing parents to learn donor identity immediately after birth.

cascadecryobank.com
3IUI A.R.T. - Cost-effective option for lower cell count requirements
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$1,500 per vial - Between 5-10 million motile cells per vial, sold in 0.5 mL units. Physician consultation recommended before purchase.

cascadecryobank.com
4ICI A.R.T. - Unprocessed specimens for ICI or IUI/IVF with medical processing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$2,000 per vial - Between 5-15 million motile cells per vial, sold in 1.0 mL units.

cascadecryobank.com
5IVF/ICSI - Specimens for ICSI procedures
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$1,400 per vial - Up to 5 million motile cells per vial, sold in 0.5 mL units. Best option for ICSI insemination. Multiple vials may be used for other procedures.

cascadecryobank.com
6Continental US Standard Shipping
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$300 - Two business day delivery, can only be shipped Monday-Wednesday.

cascadecryobank.com
7Continental US Overnight Shipping
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$395 - Priority overnight delivery, shipped Monday-Friday with delivery by 12 noon. Contact required prior to ordering.

cascadecryobank.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Cascade Cryobank is a sperm bank that recruits, screens, and cryopreserves donor sperm specimens for sale to individuals, couples, and fertility clinics pursuing assisted reproduction. It offers five vial types differentiated by processing and cell count (IUI, ICI, IUI A.R.T., ICI A.R.T., IVF/ICSI), two donor identity disclosure programs (Open ID and the industry-first Early Disclosure Program), and supporting services including cold storage and FedEx shipping in temperature-controlled dry shippers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Only ~4% of sperm donor applicants are accepted into the program
+2 more records
Product overview1 text field

Cascade Cryobank is a sperm bank providing donor sperm for assisted reproductive care. The company operates a multi-product portfolio centered on cryopreserved sperm vials available in five distinct types (IUI, ICI, IUI A.R.T., ICI A.R.T., and IVF/ICSI), differentiated by processing level and cell count specifications. Two identity disclosure programs serve different transparency preferences: the proprietary Early Disclosure Program (industry-first allowing identity release at birth) and the standard Open ID Program (identity available at age 18). The Donor Catalog provides searchable access to screened donor profiles. Supporting services include fertility financing through a CapexMD partnership, temperature-controlled shipping, and cold storage with promotional free storage periods.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-01
Description

Fertio, an international fertility care group and parent company of European Sperm Bank, acquired Cascade Cryobank in March 2026, marking its expansion into the U.S. market. The acquisition combines Fertio's 20+ years of global expertise with Cascade's Early Disclosure Program, setting new standards in the fertility industry.

2Canada Cryobank
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership with Canada Cryobank to share resources and expertise in donor screening and genetic screening, expanding reach and contributing to a more diverse donor pool while addressing growing demand for reproductive services.

cascadecryobank.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership with Monash IVF, a leading fertility provider, to enhance reproductive health services through collaboration and shared expertise in sperm banking and fertility care.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Partnership with CapexMD, a specialized patient financing lender, to offer customized loan programs from $3,000 to $50,000 with competitive rates for fertility treatment financing. Loans can include medications and other needs with terms from 6 to 60 months.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
1Xytex
TypeDirect peer
Description

U.S. sperm bank offering IUI and ICI vials with detailed donor profiles and genetic screening. Comparable to Cascade in product structure and target customers, including LGBTQ+ family building and single parents by choice.

TypeDirect peer
Description

Fertio's flagship sperm bank and now sister brand to Cascade following the March 2026 acquisition. Comparable in product offering, screening standards, and identity disclosure options, and serves as the strategic backbone for Cascade's U.S. expansion.

TypeDirect peer
Description

One of the largest U.S. sperm banks, offering a similar portfolio of IUI/ICI/IVF vials with extensive donor screening and genetic testing. Directly comparable in product offering, target market, and clinic-facing distribution.

4Cryos International
TypeDirect peer
Description

The world's largest sperm bank with operations in the U.S. and internationally. Directly competes with Cascade across vial types, donor screening, and clinic/B2B coordination. Notably, Cascade's COO Corey Burke previously held executive roles at Cryos.

TypeRegional player
Description

Pacific Northwest-based sperm bank with similar product portfolio and donor screening approach. Direct competitor in Cascade's home market, though Seattle Sperm Bank has a longer operating history and larger national footprint.

TypeDirect peer
Description

Nonprofit sperm bank known for early identity disclosure practices and an 'Identity-Release' donor program. Conceptually adjacent to Cascade's Early Disclosure Program and serves similar intended-parent segments on the West Coast.

7Monash IVF
TypeBroad incumbent
Description

Major international fertility services group and a current Cascade partner. While broader in scope (full IVF clinical services rather than a pure sperm bank), it intersects with Cascade's value chain as both a customer and a clinical partner in the reproductive services ecosystem.

TypeDirect peer
Description

Long-established U.S. sperm bank with a broad donor catalog, multi-state operations, and direct clinic and D2C channels. Closely comparable to Cascade in product mix, screening rigor, and target customer segments.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cascade Cryobank

Cascade Cryobank is a Washington-state-based FDA-registered sperm bank founded in 2022 and now a subsidiary of Fertio (European Sperm Bank's parent). It sells five cryopreserved donor sperm vial types direct-to-consumer and to fertility clinics across the U.S. and Canada, differentiated by its Early Disclosure Program and 714-condition genetic screening.

What Cascade Cryobank does

Cascade Cryobank is a Washington-state-based for-profit sperm bank founded in 2022 (per company history) and headquartered in Lynnwood, WA, operating as a wholly-owned subsidiary of Fertio, the international fertility care group that owns European Sperm Bank, following Fertio's March 2026 acquisition. The company recruits and screens sperm donors against an industry-rigorous bar — only about 4% of applicants are accepted — and processes donations through FDA-registered, CLIA-certified cryopreservation workflows meeting 21 CFR Part 1271, with state-level tissue bank licensure in Washington, New York, California, Colorado, Oregon, and Maryland, plus Health Canada Primary Establishment registration for cross-border distribution. Its core products are five cryopreserved vial types (IUI, ICI, IUI A.R.T., ICI A.R.T., and IVF/ICSI) sold direct-to-consumer via cascadecryobank.com, each with guaranteed post-thaw motile cell counts (e.g., $1,400-$2,300 per vial), supported by temperature-controlled FedEx shipping, optional long-term storage, and a CapexMD financing partnership.

The company's principal point of differentiation is the proprietary Early Disclosure Program, a first-of-its-kind identity-release framework that permits parents to access donor identifying information (name, date of birth, last known state) immediately after live birth reporting rather than at the donor-conceived child's 18th birthday, with counselor-facilitated meetings between donors and parents. Genetic depth is a second differentiator: each donor is screened against 714 recessive genetic conditions, including the seven recommended carrier conditions (SMA, sickle cell, alpha/beta thalassemia, Tay-Sachs, cystic fibrosis, fragile X), along with karyotype analysis and a four-generation family medical history.

Cascade Cryobank serves four primary customer segments — single parents by choice, LGBTQ+ individuals and couples, heterosexual couples facing male-factor infertility, and fertility clinics/reproductive healthcare providers — distributed through a hybrid DTC e-commerce plus B2B clinic coordination model. Geographic reach is anchored in the Pacific Northwest (Lynnwood HQ, with named service areas in Seattle, Portland, and Boise) but vials are shipped nationwide and now into Canada. Leadership combines founder/Medical Director Dr. John Carpenter (board-certified pathologist, Seattle-area practice since 2010) and COO Corey Burke (25+ years in reproductive health, prior EVP at Cryos International, contributed to 3,000+ births, 25+ FDA inspections led).

Cascade Cryobank firmographics

Firmographics
Name
Cascade Cryobank
Legal name
Cascade Cryobank LLC
Website
https://cascadecryobank.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
1–10 employees
Short description
Cascade Cryobank is a Washington-state-based FDA-registered sperm bank founded in 2022 and now a subsidiary of Fertio (European Sperm Bank's parent). It sells five cryopreserved donor sperm vial types direct-to-consumer and to fertility clinics across the U.S. and Canada, differentiated by its Early Disclosure Program and 714-condition genetic screening.
Ownership category
akta.pro rank

Cascade Cryobank industry classification

Industry
NAICS
Blood and Organ Banks (621991)
akta.pro industry
PRIMARYHLAGAGAK
Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAAAJAN
Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)

Keywords

  • Sperm donor bank
  • Cryopreserved donor sperm
  • Assisted reproductive services
  • Donor sperm vials
  • Fertility specimen storage

Where Cascade Cryobank is headquartered

Location

Headquarters

HQ city
Lynnwood
HQ country
United States
HQ region
North America

Offices4 records

Markets served

Cascade Cryobank business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Supply Chain, Technology or R&D, Infrastructure

Revenue model

  1. Donor Sperm Vial Sales: Primary revenue from selling cryopreserved donor sperm vials. Different vial types available: IUI (washed), ICI (unprocessed), IUI A.R.T., ICI A.R.T., and IVF/ICSI vials. Pricing varies by disclosure type (Open ID vs Early Disclosure) and cell count specifications.
  2. Specimen Storage: Long-term cold storage of purchased sperm vials. Free storage promotion offered with purchase of 2+ vials (number of vials + 2 additional months free). Storage fees apply after free period.
  3. Shipping and Delivery: Revenue from shipping specimens via FedEx in dry shippers. Standard continental US shipping $300 (2-day, Mon-Wed only), overnight priority $395 (Mon-Fri, delivery by noon). International and Alaska/Hawaii shipping available at higher rates.
  4. Sperm Donation Compensation: Donors receive compensation: $40 per initial test donation, $125 per accepted donation ($50 at time of donation, $50 after freeze/thaw test, $25 after 6-month quarantine clearance). Monthly earnings can reach up to $1,400 with bonuses. Donors earning $600+/year receive 1099 tax forms.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goIUI 10 Open ID - Washed specimens for insemination procedures with 10+ million motile cells
Unit PricingPay-as-you-goIUI 10 Early Disclosure - Premium identity disclosure option with same specifications
Unit PricingPay-as-you-goIUI A.R.T. - Cost-effective option for lower cell count requirements
Unit PricingPay-as-you-goICI A.R.T. - Unprocessed specimens for ICI or IUI/IVF with medical processing
Unit PricingPay-as-you-goIVF/ICSI - Specimens for ICSI procedures
Unit PricingPay-as-you-goContinental US Standard Shipping
Unit PricingPay-as-you-goContinental US Overnight Shipping

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Cascade Cryobank product offering

Product offering

Core offering

Cascade Cryobank is a sperm bank that recruits, screens, and cryopreserves donor sperm specimens for sale to individuals, couples, and fertility clinics pursuing assisted reproduction. It offers five vial types differentiated by processing and cell count (IUI, ICI, IUI A.R.T., ICI A.R.T., IVF/ICSI), two donor identity disclosure programs (Open ID and the industry-first Early Disclosure Program), and supporting services including cold storage and FedEx shipping in temperature-controlled dry shippers.

Product overview

Cascade Cryobank is a sperm bank providing donor sperm for assisted reproductive care. The company operates a multi-product portfolio centered on cryopreserved sperm vials available in five distinct types (IUI, ICI, IUI A.R.T., ICI A.R.T., and IVF/ICSI), differentiated by processing level and cell count specifications. Two identity disclosure programs serve different transparency preferences: the proprietary Early Disclosure Program (industry-first allowing identity release at birth) and the standard Open ID Program (identity available at age 18). The Donor Catalog provides searchable access to screened donor profiles. Supporting services include fertility financing through a CapexMD partnership, temperature-controlled shipping, and cold storage with promotional free storage periods.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • Only ~4% of sperm donor applicants are accepted into the program
  • +2 more outcomes

Companies that use Cascade Cryobank

Customer profile

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Cascade Cryobank technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Cascade Cryobank partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • FertiocoreStrategic or Co-development Partner · 1 March 2026Fertio, an international fertility care group and parent company of European Sperm Bank, acquired Cascade Cryobank in March 2026, marking its expansion into the U.S. market. The acquisition combines Fertio's 20+ years of global expertise with Cascade's Early Disclosure Program, setting new standards in the fertility industry.
  • Canada CryobankminorStrategic or Co-development PartnerPartnership with Canada Cryobank to share resources and expertise in donor screening and genetic screening, expanding reach and contributing to a more diverse donor pool while addressing growing demand for reproductive services.
  • Monash IVFminorStrategic or Co-development PartnerPartnership with Monash IVF, a leading fertility provider, to enhance reproductive health services through collaboration and shared expertise in sperm banking and fertility care.
  • CapexMDminorGTM or Marketing PartnerPartnership with CapexMD, a specialized patient financing lender, to offer customized loan programs from $3,000 to $50,000 with competitive rates for fertility treatment financing. Loans can include medications and other needs with terms from 6 to 60 months.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Cascade Cryobank competitors and assessment

Company assessment

Direct peers

  • Xytex: U.S. sperm bank offering IUI and ICI vials with detailed donor profiles and genetic screening. Comparable to Cascade in product structure and target customers, including LGBTQ+ family building and single parents by choice.
  • European Sperm Bank: Fertio's flagship sperm bank and now sister brand to Cascade following the March 2026 acquisition. Comparable in product offering, screening standards, and identity disclosure options, and serves as the strategic backbone for Cascade's U.S. expansion.
  • Fairfax Cryobank: One of the largest U.S. sperm banks, offering a similar portfolio of IUI/ICI/IVF vials with extensive donor screening and genetic testing. Directly comparable in product offering, target market, and clinic-facing distribution.
  • Cryos International: The world's largest sperm bank with operations in the U.S. and internationally. Directly competes with Cascade across vial types, donor screening, and clinic/B2B coordination. Notably, Cascade's COO Corey Burke previously held executive roles at Cryos.
  • The Sperm Bank of California: Nonprofit sperm bank known for early identity disclosure practices and an 'Identity-Release' donor program. Conceptually adjacent to Cascade's Early Disclosure Program and serves similar intended-parent segments on the West Coast.
  • California Cryobank: Long-established U.S. sperm bank with a broad donor catalog, multi-state operations, and direct clinic and D2C channels. Closely comparable to Cascade in product mix, screening rigor, and target customer segments.

Regional players

  • Seattle Sperm Bank: Pacific Northwest-based sperm bank with similar product portfolio and donor screening approach. Direct competitor in Cascade's home market, though Seattle Sperm Bank has a longer operating history and larger national footprint.

Broad incumbents

  • Monash IVF: Major international fertility services group and a current Cascade partner. While broader in scope (full IVF clinical services rather than a pure sperm bank), it intersects with Cascade's value chain as both a customer and a clinical partner in the reproductive services ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Cascade Cryobank social profiles

Digital presence

Cascade Cryobank compliance and trust

Trust signal

Compliance5 records

Cascade Cryobank financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cascade Cryobank leadership team

Management profile

Number of profiles

Profiles2 records

Cascade Cryobank funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cascade Cryobank M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cascade Cryobank

What does Cascade Cryobank do?

Cascade Cryobank is a sperm bank that recruits, screens, and cryopreserves donor sperm specimens for sale to individuals, couples, and fertility clinics pursuing assisted reproduction. It offers five vial types differentiated by processing and cell count (IUI, ICI, IUI A.R.T., ICI A.R.T., IVF/ICSI), two donor identity disclosure programs (Open ID and the industry-first Early Disclosure Program), and supporting services including cold storage and FedEx shipping in temperature-controlled dry shippers.

Is Cascade Cryobank a public or private company?

Cascade Cryobank is a private company. It is currently operating.

When was Cascade Cryobank founded?

Cascade Cryobank was founded in 2022. It employs 1 to 10 people.

Where is Cascade Cryobank based?

Cascade Cryobank is headquartered in Lynnwood, United States, in the North America region.

How does Cascade Cryobank make money?

Four revenue lines are on record. Donor Sperm Vial Sales are the primary driver. The others are specimen Storage, shipping and Delivery and sperm Donation Compensation.

Who are Cascade Cryobank's main competitors?

Direct peers on record are Xytex, European Sperm Bank, Fairfax Cryobank, Cryos International, The Sperm Bank of California and California Cryobank. Seattle Sperm Bank is listed as a regional player. Monash IVF is listed as a broad incumbent.

Does Cascade Cryobank have an API?

No public API is recorded for Cascade Cryobank.

What industry is Cascade Cryobank in?

Its primary akta.pro industry code is HLAGAGAK, Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low), with a secondary code of HLAAAJAN, Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies. Its NAICS code is 621991.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Pulse 2.0Fertio Acquires Cascade Cryobank To Expand U.S. Presence And Donor TransparencyFertio, an international fertility care group and parent company of European Sperm Bank, has acquired Cascade Cryobank, a U.S.-based sperm bank founded in 2021, marking Fertio's entry into the United States market. The acquisition combines Fertio's more than 20 years of global experience with Cascade's Early Disclosure Program, which enables parents to access donor identity information immediately after a child's birth. Following the transaction, Cascade Cryobank will continue operating under its existing brand while leveraging Fertio's scale, donor management technology, and international expertise to expand services and set new quality benchmarks in the fertility care industry.HomepageFertio Acquires U.S. Sperm Bank Cascade Cryobank, Expanding Into the American MarketFertio, the international fertility care group behind European Sperm Bank, has acquired Cascade Cryobank, a Washington state-based sperm bank, marking its expansion into the U.S. market. The acquisition brings together Fertio's 20+ years of global expertise with Cascade's Early Disclosure Program, which allows parents to access donor identity information immediately after birth rather than waiting until the donor-conceived child turns 18. Financial terms were not disclosed, and the deal reflects continued consolidation in the fertility services space as global reproductive health platforms expand their U.S. footprint through acquisitions.Business Wire BlogFertio Acquires Cascade Cryobank, Expanding Fertility Care and Donor TransparencyFertio, an international fertility care group and parent company of European Sperm Bank, announced its expansion into the United States through the acquisition of Cascade Cryobank, a Lynnwood, WA sperm bank founded in 2021. The deal combines Fertio's 20+ years of global expertise with Cascade's Early Disclosure Program, which allows parents to access donor identity information immediately after birth—an industry-first. Both companies characterized the partnership as a strategic milestone that will advance fertility care and family-building options for U.S. parents while setting new standards in the fertility industry.